Health Economics Facility / Dep. of Public Health at the Faculty of Medicine
The health economic activities at the Medical Faculty, initiated in 2003, are located at the Department of Public Health, with its full members Institute/European Center of Pharmaceutical Medicine and Institute of Nursing Science.
These activities are currently being bundled at the Health Economics Facility.
Research activities occur at the interface of economics and clinical epidemiology/medicine. They focus on Health Technology Assessment, particularly the cost-benefit implications and efficient use of pharmaceuticals and other healthcare interventions in Switzerland and internationally. Complementary activities occur in health services research. Current projects address, e.g., value-based health care in lung cancer patients, antimicrobial resistance, and early estimation of health economic characteristics of an emerging gene delivery technology.
Michaela Barbier, PhD, is a senior scientist in health economics and modeling at ECPM and has a background in biostatistics. Her main interests lie in the area of health economic evaluations, benefits in health care, health services research and the analysis of real data.
Jana Bartakova, PhD, is a postdoctoral researcher at the Institute for Nursing Science (INS) at the University of Basel, with a degree in systematic integration processes in healthcare and a PhD in health economics. Her research experiences include health economic evaluations in implementation science and, in addition to clinical studies, labor market analyzes in the healthcare sector, HTA, quality of life research and health economic modeling.
Mark Lambiris, PhD, is a senior health economist at the Health Economics Facility at the Faculty of Medicine and the Institute of Pharmaceutical Medicine (University of Basel). His research activities include health economic evaluations (cost-effectiveness analyzes of drugs or interventions), the application of causality inference methods to real-world data (health insurance claims, electronic medical records, social security datasets), implementation research, and evidence synthesis (meta-analysis). His work has spanned multiple disease and health areas, including infectious diseases, antimicrobial resistance, child and cognitive development, mental health, cancer and multiple sclerosis. He uses both frequentist and Bayesian statistical methods.
Judith Lupatsch, PhD, is a senior research scientist and lecturer at the Institute of Pharmaceutical Medicine. Her research interests focus on health economics, HTA, epidemiology and health services research, especially modeling aspects.
Niklaus Meier has been a doctoral student in public health and epidemiology at the University of Basel since January 2021 under the supervision of Prof. Thomas Szucs and specializes in health technology assessment and cost-effectiveness analyzes for pharmaceuticals.
Dante Jr Salvador
Dante Jr Salvador, MD, PhD, is a senior research scientist in health economics at ECPM and Health Economics Facility, Department of Public Health with degrees in biology, public management, and public health, and doctorates in medicine, and epidemiology and biostatistics. His research experience and methodological interests include: health economic evaluation, health technology assessment, systematic reviews and meta-analyses, health financing, and cardiometabolic epidemiology.
Nadine Schur is a senior research scientist at the Institute of Pharmaceutical Medicine (ECPM) at the University of Basel. She has a degree in biomathematics and a doctorate in epidemiology. Her research interests lie in the analysis of real-world databases, health economic evaluations and decision-analytic modeling.
Matthias Schwenkglenks heads the Health Economics Facility at the Department of Public Health at the Medical Faculty of the University of Basel and is head of research at the Institute for Pharmaceutical Medicine (ECPM). He also holds an adjunct professorship at the Medical Faculty of the University of Zurich. His research focuses on health economic evaluation (cost-effectiveness, cost-utility studies) and health services research with large, administrative data sets. A planned focus of future research is the influence of the design of insurance and reimbursement systems on the use and quality of health services.
Sandro Stoffel, PhD, is a senior research scientist with experience in behavioral health economics, medical decision-making, health psychology, and survey methodology.